GBGT1 and ovarian cancer: Our results identify GBGT1 as the most differentially expressed Fs-biosynthesis-relevant glycogene among the cell lines investigated and provide evidence that DNA methylation at its promoter region is one mechanism by which GBGT1 expression is regulated on the transcriptional level in ovarian cancer.